131 related articles for article (PubMed ID: 28645097)
1. Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines.
Franco D; Trusso S; Fazio E; Allegra A; Musolino C; Speciale A; Cimino F; Saija A; Neri F; Nicolò MS; Guglielmino SPP
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Dec; 187():15-22. PubMed ID: 28645097
[TBL] [Abstract][Full Text] [Related]
2. Micro-Raman spectroscopy detects individual neoplastic and normal hematopoietic cells.
Chan JW; Taylor DS; Zwerdling T; Lane SM; Ihara K; Huser T
Biophys J; 2006 Jan; 90(2):648-56. PubMed ID: 16239327
[TBL] [Abstract][Full Text] [Related]
3. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells.
Tibullo D; Giallongo C; Romano A; Vicario N; Barbato A; Puglisi F; Parenti R; Amorini AM; Wissam Saab M; Tavazzi B; Mangione R; Brundo MV; Lazzarino G; Palumbo GA; Volti GL; Raimondo FD; Lazzarino G
Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365811
[TBL] [Abstract][Full Text] [Related]
5. Raman micro-spectroscopy applied to treatment resistant and sensitive human ovarian cancer cells.
Moradi H; Ahmad A; Shepherdson D; Vuong NH; Niedbala G; Eapen L; Vanderhyden B; Nyiri B; Murugkar S
J Biophotonics; 2017 Oct; 10(10):1327-1334. PubMed ID: 28009133
[TBL] [Abstract][Full Text] [Related]
6. Biochemical signatures of in vitro radiation response in human lung, breast and prostate tumour cells observed with Raman spectroscopy.
Matthews Q; Jirasek A; Lum JJ; Brolo AG
Phys Med Biol; 2011 Nov; 56(21):6839-55. PubMed ID: 21971286
[TBL] [Abstract][Full Text] [Related]
7. Raman micro-spectroscopy analysis of different sperm regions: a species comparison.
Amaral S; Da Costa R; Wübbeling F; Redmann K; Schlatt S
Mol Hum Reprod; 2018 Apr; 24(4):185-202. PubMed ID: 29528451
[TBL] [Abstract][Full Text] [Related]
8. Cellular discrimination using in vitro Raman micro spectroscopy: the role of the nucleolus.
Farhane Z; Bonnier F; Casey A; Maguire A; O'Neill L; Byrne HJ
Analyst; 2015 Sep; 140(17):5908-19. PubMed ID: 26207998
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of uterine sarcoma cell lines exhibiting MDR phenotype by vibrational spectroscopy.
Murali Krishna C; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
Biochim Biophys Acta; 2005 Nov; 1726(2):160-7. PubMed ID: 16169664
[TBL] [Abstract][Full Text] [Related]
10. Raman micro spectroscopy for in vitro drug screening: subcellular localisation and interactions of doxorubicin.
Farhane Z; Bonnier F; Casey A; Byrne HJ
Analyst; 2015 Jun; 140(12):4212-23. PubMed ID: 25919793
[TBL] [Abstract][Full Text] [Related]
11. hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10.
Xi H; Li L; Du J; An R; Fan R; Lu J; Wu YX; Wu SX; Hou J; Zhao LM
Oncol Rep; 2017 Feb; 37(2):961-968. PubMed ID: 28000886
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma.
Noborio-Hatano K; Kikuchi J; Takatoku M; Shimizu R; Wada T; Ueda M; Nobuyoshi M; Oh I; Sato K; Suzuki T; Ozaki K; Mori M; Nagai T; Muroi K; Kano Y; Furukawa Y; Ozawa K
Oncogene; 2009 Jan; 28(2):231-42. PubMed ID: 18850009
[TBL] [Abstract][Full Text] [Related]
13. Resonance Raman and Raman spectroscopy for breast cancer detection.
Liu CH; Zhou Y; Sun Y; Li JY; Zhou LX; Boydston-White S; Masilamani V; Zhu K; Pu Y; Alfano RR
Technol Cancer Res Treat; 2013 Aug; 12(4):371-82. PubMed ID: 23448574
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 (ET-1) induces resistance to bortezomib in human multiple myeloma cells via a pathway involving the ETB receptor and upregulation of proteasomal activity.
Vaiou M; Pangou E; Liakos P; Sakellaridis N; Vassilopoulos G; Dimas K; Papandreou C
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2141-58. PubMed ID: 27530445
[TBL] [Abstract][Full Text] [Related]
15. A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures.
Fazio E; Trusso S; Franco D; Nicolò MS; Allegra A; Neri F; Musolino C; Guglielmino SP
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Apr; 159():21-9. PubMed ID: 26827173
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma.
Siegel MB; Liu SQ; Davare MA; Spurgeon SE; Loriaux MM; Druker BJ; Scott EC; Tyner JW
Oncotarget; 2015 Aug; 6(22):18921-32. PubMed ID: 26254279
[TBL] [Abstract][Full Text] [Related]
17. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
[TBL] [Abstract][Full Text] [Related]
18. Raman micro-spectroscopy for rapid screening of oral squamous cell carcinoma.
Carvalho LF; Bonnier F; O'Callaghan K; O'Sullivan J; Flint S; Byrne HJ; Lyng FM
Exp Mol Pathol; 2015 Jun; 98(3):502-9. PubMed ID: 25805102
[TBL] [Abstract][Full Text] [Related]
19. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD
Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174
[TBL] [Abstract][Full Text] [Related]
20. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC
Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
